Both in Pharmaceuticals
Veru vs Impact BioMedical
Over the past year VERU returned −44.0% and IBO returned −64.4%; their daily moves had a correlation of 0.05.
VERU −44.0% IBO −64.4%Growth of $1, one year, split-adjusted
| Metric | VERU | IBO |
|---|---|---|
| Price | $2.30 | $2.68 |
| Market cap | $39.2M | $22.9M |
| Today | −5.74% | −15.15% |
| 1 month | −3.8% | −62.8% |
| 6 months | −5.7% | −67.1% |
| Year to date | +7.5% | −57.9% |
| 1 year | −47.6% | −64.8% |
| Revenue growth (YoY) | — | −57.1% |
| Gross margin | — | −533.3% |
| Net margin | — | −23300.0% |
| P/E (TTM) | — | 29.0× |
| Price / sales | — | 654.2× |
| Net cash | $25.8M | $10.0K |
| Dividend yield | — | — |
| Volatility (60d) | 63.6% | 733.9% |
| Short % of float | 9.7% | 0.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).